Karel Urbanek

Dr. Karel Urbanek

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
Milan KolarMilan Kolar
Milan Kolar
KUKarel Urbanek
Karel Urbanek
TLTomáš Látal
Tomáš Látal

25 May 2010 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
IVIlona Vinklerová
Ilona Vinklerová
MPMichal Procházka
Michal Procházka
VPVlastimil Procházka
Vlastimil Procházka
KUKarel Urbanek
Karel Urbanek

1 February 2006 in Pharmacological Research
Verified
Journal Article
Closed access
LSLucie Sobolová
Lucie Sobolová
NŠNina Škottová
Nina Škottová
RVRostislav Večeřa
Rostislav Večeřa
KUKarel Urbanek
Karel Urbanek

1 January 2003 in Pharmacological Research
Verified
Journal Article
Closed access
NŠNina Škottová
Nina Škottová
RVRostislav Večeřa
Rostislav Večeřa
KUKarel Urbanek
Karel Urbanek
PVPetr Váňa
Petr Váňa
DWDaniela Walterová
Daniela Walterová
LCLadislav Cvak
Ladislav Cvak

16 July 2014 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MSMiroslava Htoutou Sedláková
Miroslava Htoutou Sedláková
KUKarel Urbanek
Karel Urbanek
VVVladimíra Vojtová
Vladimíra Vojtová
HSHana Suchánková
Hana Suchánková
PIPeter Imwensi
Peter Imwensi
Milan KolarMilan Kolar
Milan Kolar
Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics.

17 July 2007 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
KUKarel Urbanek
Karel Urbanek
Milan KolarMilan Kolar
Milan Kolar
YLY. Lovečková
Y. Lovečková
JSJ. Strojil
J. Strojil
LŠL. Šantavá
L. Šantavá
Background: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc. Methods: Data on the utilization of antibiotics in the hospital were obtained for the period 1997–2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients. Results: Consumption of third-generation cephalosporins, which was 1·79 DBD in 1997, decreased to 0·93 in 1999, remained stable until 2002, and then increased to 2·40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%. Conclusions: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.